| Dr Richard Paul Sturtz, MD | |
|
1114 Cornelia Rd, Anderson, SC 29621-3317 | |
| (864) 225-1656 | |
| (864) 225-1658 |
| Full Name | Dr Richard Paul Sturtz |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Location | 1114 Cornelia Rd, Anderson, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770799751 | NPI | - | NPPES |
| 114931 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 11493 (South Carolina) | Primary |
| Entity Name | Dermatology Clinic, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518929694 PECOS PAC ID: 2264613124 Enrollment ID: O20110224000824 |
News Archive
In a retrospective study of trauma patients over 65 years of age attended by KSS, it was found that, although a number of these patients had sustained a minor injury through seemingly innocuous mechanisms, a high proportion of this group required advanced clinical interventions and subsequent tertiary level care at a major trauma center.
Soligenix, Inc., a development stage biopharmaceutical company, announced today that the National Cancer Institute has awarded Soligenix a Small Business Innovation Research grant to support the conduct of a Phase 2 clinical trial designed to evaluate orBec (oral beclomethasone 17,21-dipropionate or BDP) as a treatment for the gastrointestinal manifestation of chronic Graft-versus-Host disease.
Dr. Harry Ostrer, professor of pediatrics, pathology and medicine at NYU Langone Medical Center will be conducting genetic screening at four college campuses in Boston on February 1st and 2nd. Individuals interested in being screened should sign- up online at www.med.nyu.edu/genetics.
Researchers in the Center for Information and Neural Networks, the National Institute of Information and Communications Technology, Japan and the Centre national de la recherché scientifique, France used fMRI to discover a new neural mechanism involving the dorsal anterior cingulate cortex to explain how anxiety deteriorates physical performance.
Venaxis, Inc., an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked APPY1™ Test, a rapid, multiple biomarker-based index assay for identifying patients that are at low risk for appendicitis, today announced that it has filed a 510(k) premarket submission for the APPY1 Test. Venaxis has requested concurrent de novo determination and 510(k) clearance from the U.S. Food and Drug Administration.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard Paul Sturtz, MD 1114 Cornelia Rd, Anderson, SC 29621-3317 Ph: (864) 225-1656 | Dr Richard Paul Sturtz, MD 1114 Cornelia Rd, Anderson, SC 29621-3317 Ph: (864) 225-1656 |
News Archive
In a retrospective study of trauma patients over 65 years of age attended by KSS, it was found that, although a number of these patients had sustained a minor injury through seemingly innocuous mechanisms, a high proportion of this group required advanced clinical interventions and subsequent tertiary level care at a major trauma center.
Soligenix, Inc., a development stage biopharmaceutical company, announced today that the National Cancer Institute has awarded Soligenix a Small Business Innovation Research grant to support the conduct of a Phase 2 clinical trial designed to evaluate orBec (oral beclomethasone 17,21-dipropionate or BDP) as a treatment for the gastrointestinal manifestation of chronic Graft-versus-Host disease.
Dr. Harry Ostrer, professor of pediatrics, pathology and medicine at NYU Langone Medical Center will be conducting genetic screening at four college campuses in Boston on February 1st and 2nd. Individuals interested in being screened should sign- up online at www.med.nyu.edu/genetics.
Researchers in the Center for Information and Neural Networks, the National Institute of Information and Communications Technology, Japan and the Centre national de la recherché scientifique, France used fMRI to discover a new neural mechanism involving the dorsal anterior cingulate cortex to explain how anxiety deteriorates physical performance.
Venaxis, Inc., an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked APPY1™ Test, a rapid, multiple biomarker-based index assay for identifying patients that are at low risk for appendicitis, today announced that it has filed a 510(k) premarket submission for the APPY1 Test. Venaxis has requested concurrent de novo determination and 510(k) clearance from the U.S. Food and Drug Administration.
› Verified 7 days ago
Dr. Theresa Greene Knoepp, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1501 N Main St, Anderson, SC 29621 Phone: 864-716-0063 Fax: 864-716-0073 | |
Mark Johnson Quarterman, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2022 Cardinal Cir, Anderson, SC 29621 Phone: 864-224-7577 Fax: 864-225-5165 | |
Richard John Deangelis, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1409 N Fant St, Anderson, SC 29621 Phone: 864-231-8599 Fax: 864-231-8073 | |
Dr. Arthur J Dean Jr., M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1501 N Main St, Anderson, SC 29621 Phone: 864-716-0063 Fax: 864-716-0073 | |
Katherine R Shew, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1501 N Main St, Anderson, SC 29621 Phone: 864-716-0063 Fax: 864-716-0073 | |
Brian Wanner, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1409 N. Fant Street, Anderson, SC 29621 Phone: 864-375-7551 Fax: 864-231-8073 |